- Home
- EVCM vs INBX Comparison
EVCM vs INBX Comparison
Compare EVCM & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVCM | INBX |
|---|---|---|
| Founded | 2006 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2021 | 2024 |
Fundamental Metrics
Financial Performance| Metric | EVCM | INBX |
|---|---|---|
| Price | $6.44 | $110.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 3 |
| Target Price | $10.67 | ★ $150.00 |
| AVG Volume (30 Days) | 130.7K | ★ 317.9K |
| Earning Date | 05-07-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 145.45 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $588,907,000.00 | $1,300,000.00 |
| Revenue This Year | $7.39 | N/A |
| Revenue Next Year | $5.84 | N/A |
| P/E Ratio | $73.67 | ★ N/A |
| Revenue Growth | N/A | ★ 550.00 |
| 52 Week Low | $6.63 | $26.19 |
| 52 Week High | $14.41 | $155.29 |
Technical Indicators
Market Signals| Indicator | EVCM | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 18.95 | 51.54 |
| Support Level | N/A | $70.23 |
| Resistance Level | $12.45 | $131.01 |
| Average True Range (ATR) | 0.50 | 10.16 |
| MACD | -0.24 | -1.30 |
| Stochastic Oscillator | 0.15 | 43.91 |
Price Performance
Historical ComparisonAbout EVCM EverCommerce Inc.
EverCommerce Inc provides tailored Software-as-a-Service solutions for service-based small- and medium-sized businesses (SMBs) in-home services, health services, and fitness & wellness. The Company served more than 745,000 customers across three core verticals: EverPro for Home Services; EverHealth for Health Services; and EverWell for Wellness Services. Revenue is mostly generated from the United States. Operating in a single segment, their vertically-tailored SaaS offerings cater to SMBs' specialized demands, enabling them to automate processes, generate business, and enhance customer loyalty.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.